Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma.
作者信息
Pinton Giulia, Moro Laura
机构信息
Department of Pharmaceutical Sciences, University of Piemonte Orientale, Novara, Italy.
出版信息
Future Sci OA. 2017 Feb 17;3(2):FSO175. doi: 10.4155/fsoa-2017-0007. eCollection 2017 Jun.
Abstract
摘要
相似文献
1
Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma.雌激素受体β在恶性胸膜间皮瘤中的表达及治疗意义
Future Sci OA. 2017 Feb 17;3(2):FSO175. doi: 10.4155/fsoa-2017-0007. eCollection 2017 Jun.
2
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.雌激素受体β（ERβ）在胸膜间皮瘤中的表达及其预后价值。
J Thorac Dis. 2019 Apr;11(4):1456-1464. doi: 10.21037/jtd.2019.03.38.
3
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.细胞内乳酸介导的双相恶性胸膜间皮瘤细胞中雌激素受体β（ERβ）的诱导
Oncotarget. 2015 Sep 22;6(28):25121-34. doi: 10.18632/oncotarget.4486.
4
Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.雌激素受体-β影响人类恶性间皮瘤的预后。
Cancer Res. 2009 Jun 1;69(11):4598-604. doi: 10.1158/0008-5472.CAN-08-4523.
5
Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma.甾体激素受体共激活因子 SRC-2/TIF-2 的持续表达与恶性胸膜间皮瘤的较好预后相关。
J Thorac Oncol. 2012 Jan;7(1):243-8. doi: 10.1097/JTO.0b013e31822f6544.
6
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.雌激素受体β（ERβ）的激动剂激活使恶性胸膜间皮瘤细胞对顺铂细胞毒性敏感。
Mol Cancer. 2014 Oct 2;13:227. doi: 10.1186/1476-4598-13-227.
7
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.选择性表皮生长因子受体酪氨酸激酶抑制剂PD153035在体外抑制恶性胸膜间皮瘤细胞中促转移表型的表达。
J Thorac Cardiovasc Surg. 2005 May;129(5):1010-7. doi: 10.1016/j.jtcvs.2004.10.040.
8
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.KDM6B组蛋白去甲基化酶是人类胸膜间皮瘤中雌激素受体β表达的一种表观遗传调节剂。
Epigenomics. 2016 Sep;8(9):1227-38. doi: 10.2217/epi-2016-0025. Epub 2016 Aug 16.
9
10
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.恶性胸膜间皮瘤患者生存的预后因素：国家癌症数据库分析。
Carcinogenesis. 2019 Jun 10;40(4):529-536. doi: 10.1093/carcin/bgz004.
引用本文的文献
1
The Relationship Between Periodontal Disease and Breast Cancer: From Basic Mechanism to Clinical Management and Prevention.牙周病与乳腺癌的关系：从基础机制到临床管理与预防。
Oral Health Prev Dent. 2023 Feb 16;21:49-60. doi: 10.3290/j.ohpd.b3904343.
2
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review.雌激素受体在胸部恶性肿瘤中的表达及临床意义：一项叙述性综述
J Thorac Dis. 2021 Mar;13(3):1851-1863. doi: 10.21037/jtd-20-2277.
3
Gender Differences in Outcomes of Patients With Mesothelioma.间皮瘤患者结局的性别差异。
Am J Clin Oncol. 2020 Nov;43(11):792-797. doi: 10.1097/COC.0000000000000745.
4
Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.雌激素受体β（ERβ）在胸膜间皮瘤中的表达及其预后价值。
J Thorac Dis. 2019 Apr;11(4):1456-1464. doi: 10.21037/jtd.2019.03.38.
5
Prognostic factors of survival in patients with malignant pleural mesothelioma: an analysis of the National Cancer Database.恶性胸膜间皮瘤患者生存的预后因素：国家癌症数据库分析。
Carcinogenesis. 2019 Jun 10;40(4):529-536. doi: 10.1093/carcin/bgz004.
本文引用的文献
1
Estrogen Receptor β as a Pharmaceutical Target.雌激素受体 β 作为药物靶点。
Trends Pharmacol Sci. 2017 Jan;38(1):92-99. doi: 10.1016/j.tips.2016.10.006. Epub 2016 Dec 13.
2
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.KDM6B组蛋白去甲基化酶是人类胸膜间皮瘤中雌激素受体β表达的一种表观遗传调节剂。
Epigenomics. 2016 Sep;8(9):1227-38. doi: 10.2217/epi-2016-0025. Epub 2016 Aug 16.
3
Estrogen receptor alpha and beta in health and disease.健康与疾病中的雌激素受体α和β
Best Pract Res Clin Endocrinol Metab. 2015 Aug;29(4):557-68. doi: 10.1016/j.beem.2015.04.008. Epub 2015 Apr 26.
4
Characterization of hypoxia in malignant pleural mesothelioma with FMISO PET-CT.采用 FMISO PET-CT 对恶性胸膜间皮瘤的缺氧进行特征描述。
Lung Cancer. 2015 Oct;90(1):55-60. doi: 10.1016/j.lungcan.2015.07.015. Epub 2015 Jul 30.
5
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells.细胞内乳酸介导的双相恶性胸膜间皮瘤细胞中雌激素受体β（ERβ）的诱导
Oncotarget. 2015 Sep 22;6(28):25121-34. doi: 10.18632/oncotarget.4486.
6
Second line therapy in malignant pleural mesothelioma: A systematic review.恶性胸膜间皮瘤的二线治疗：一项系统评价。
Lung Cancer. 2015 Sep;89(3):223-31. doi: 10.1016/j.lungcan.2015.06.018. Epub 2015 Jun 23.
7
The global spread of asbestos.石棉的全球传播。
Ann Glob Health. 2014 Jul-Aug;80(4):257-62. doi: 10.1016/j.aogh.2014.09.016. Epub 2014 Nov 25.
8
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity.雌激素受体β（ERβ）的激动剂激活使恶性胸膜间皮瘤细胞对顺铂细胞毒性敏感。
Mol Cancer. 2014 Oct 2;13:227. doi: 10.1186/1476-4598-13-227.
9
Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.碳酸酐酶 IX（CAIX）在恶性间皮瘤中的表达。免疫组织化学和免疫细胞化学研究。
Neoplasma. 2014;61(2):161-9. doi: 10.4149/neo_2014_031.
10
Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo.雌激素受体 β 激活可损害线粒体氧化代谢，并影响恶性间皮瘤细胞在体外和体内的生长。
Oncogenesis. 2013 Sep 23;2(9):e72. doi: 10.1038/oncsis.2013.32.
Zotero 插件